期刊文献+

骨化三醇在肾功能衰竭患者血液透析中的应用效果

Application effect of calcitriol in the hematodialysis of patients with renal failure
下载PDF
导出
摘要 目的:观察与分析骨化三醇在肾功能衰竭患者血液透析中的应用效果。方法:选取采取血液透析方式进行治疗的肾功能衰竭患者100例,患者在入院后给予原发病的对症治疗,在此基础上,每周进行2~3次血液透析,每次持续时间3~4小时,在血液透析的同时加用骨化三醇进行静脉注射。结果:治疗3个月后,患者的血钙水平较治疗前有所升高,但差异无统计学意义(t=12.21,P>0.05);患者的血磷水平较治疗前有显著降低,比较差异具有统计学意义(t=22.56,P<0.05);患者的钙磷乘积值较治疗前显著降低,比较差异具有统计学意义(t=25.00,P<0.05)。结论:在慢性肾功能衰竭患者血液透析治疗过程中,应用骨化三醇能够很好地改善患者的肾功能,使患者的血钙、血磷平衡得到良好的调节。 Objective:To observe and analyze the application effect of calcitriol in the hematodialysis of patients with renal failure.Methods:100 patients with renal failure were selected,and they were treated with hemodialysis treatment.The patients were treated with primary disease treatment after admission.On this basis,all patients were treated with 2~3 times hemodialysis every week.The every time duration was 3~4 hours.All patients were treated with intravenous calcitriol at the same time of hemodialysis.Results:After 3 months of treatment,the serum calcium level of patients was increased than that of before treatment,but the difference was not statistically significant(t=12.21,P>0.05).The serum phosphate level of patients was significantly decreased than that of before treatment,the difference was statistically significant(t=22.56,P<0.05).The calcium-phosphorus product value was significantly lower than that of before treatment,the difference was statistically significant(t=25.00,P<0.05).Conclusion:In the hematodialysis treatment process of patients with chronic renal failure,calcitriol can well improve the renal function of the patients,make a good regulation of the serum calcium and serum phosphorus balance.
作者 郭瑞
出处 《中国社区医师(医学专业)》 2014年第12期77-77,79,共2页
关键词 骨化三醇 肾功能衰竭 血液透析 Calcitriol Renal failure Hematodialysis
  • 相关文献

参考文献3

二级参考文献10

  • 1张利,陈香美,申力军,张冬.老年血液透析患者死亡相关因素分析[J].中国老年学杂志,2005,25(4):359-361. 被引量:19
  • 2黎磊石,刘志红主编.中国肾脏病学[M].北京:人民军医出版社,2008,1328-1338
  • 3洪虹,苗华.骨化三醇联合低钙透析在维持性血液透析老年患者中的应用——附17例报告[J].新医学,2007,38(7):460-461. 被引量:4
  • 4Weber S,Sehneider L.Peters Met alovel paracellin-1 mutations in 25 families with familial hypomagnesemia with hypercalciuria and nephrocalcinosis [J].J Am Soc Nephrol,2001,12(9):1872-1881.
  • 5Tentori F,Blayney MJ,Albert JM,et al. Mortality risk for dialysis patients with different levels of serum calcium,phosphorus,and PTH:the Dialysis Outcomes and Practice Patterns Study (DOPPS)[J].Am J Kidney Dis, 2008,52(3):519-530.
  • 6王海燕 王梅 左力.慢性肾脏病及透析的临床实践指南[M].北京:人民卫生出版社,2004.289-292.
  • 7王海燕 主译.慢性肾脏病及透析的临床实践指南[M].北京:人民卫生出版社,2003.69-75.
  • 8陈灏珠 朱禧星 沈稚舟.实用内科学[M]第11版[M].北京:人民卫生出版社,2004.1151.
  • 9MCINTYRE C W, PATEL V, TAYLOR G S, et al. A prospective study of combination therapy for hyperphosphataemia with calcium - containing phosphate binders and sevelamer in hypercalcaemic haemodialysis patients [ J]. Nephrol Dial Transplant, 2002, 17 (9): 1643-1648.
  • 10余国洪,杨志鹏.骨化三醇对长期维持腹膜透析患者血清钙 磷水平的影响——附38例临床分析[J].新医学,2004,35(3):162-162. 被引量:2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部